​

Funding Round

Series A - Gallant Therapeutics

Series A - Gallant Therapeutics

Investment Firm

Overview

Gallant Therapeutics is an animal health biotechnology company.

Announced Date

Jan 08, 2024

Closed on Date

Jan 08, 2024

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Bold Capital Partners

Bold Capital Partners

Bold Capital Partners is a convertible_note and early_stage_venture and seed and venture firm.

Participant Investors

2

Investor Name
Participant InvestorDigitalis Ventures
Participant InvestorBold Capital Partners

Round Details and Background

Gallant Therapeutics raised $15000000 on 2024-01-08 in Series A

Gallant Therapeutics is an animal health biotechnology company.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 08, 2024
Series A - Gallant Therapeutics
3-15.0M

Recent Activity

There is no recent news or activity for this profile.